Source:http://linkedlifedata.com/resource/pubmed/id/19208038
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0027627,
umls-concept:C0044602,
umls-concept:C0164786,
umls-concept:C0285761,
umls-concept:C0694888,
umls-concept:C0812228,
umls-concept:C1150481,
umls-concept:C1269955,
umls-concept:C1314939,
umls-concept:C1368105,
umls-concept:C1451005,
umls-concept:C1704259,
umls-concept:C1705325,
umls-concept:C1705987,
umls-concept:C2239176,
umls-concept:C2699153
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-11
|
pubmed:abstractText |
Aim: To investigate the status of Phosphatidylinositol 3-kinase (PI3K)/PTEN/AKT/mammalian target of rapamycin (mTOR) pathway and its correlation with clinicopathological features and matrix metalloproteinase-2, -9 (MMP-2, 9) in human hepatocellular carcinoma (HCC). Methods: PTEN, Phosphorylated AKT (p-AKT), Phosphorylated mTOR (p-mTOR), MMP-2, MMP-9 and Ki-67 expression levels were evaluated by immunohistochemistry on tissue microarrays containing 200 HCCs with paired adjacent non-cancerous liver tissues. PTEN, MMP-2 and MMP-9 mRNA levels were determined by real-time RT-PCR in 36 HCCs. The relationships between PI3K/PTEN/AKT/mTOR pathway and clinicopathological factors and MMP-2, 9 were analyzed in HCC. Results: In HCC, PTEN loss and overexpression of p-AKT and p-mTOR were associated with tumor grade, intrahepatic metastasis, vascular invasion, TNM stage and high Ki-67 labeling index (P < 0.05). PTEN loss was correlated with p-AKT, p-mTOR and MMP-9 overexpression. Furthermore, PTEN and MMP-2, 9 mRNA levels were down-regulated and up-regulated in HCC compared with paired non-cancerous liver tissues, respectively (P < 0.01). PTEN, MMP-2 and MMP-9 mRNA levels were correlated with tumor stage and metastasis. There was an inverse correlation between PTEN and MMP-9 mRNA expression. However, PI3K/PTEN/AKT/mTOR pathway was not correlated with MMP-2. Conclusions: PI3K/PTEN/AKT/mTOR pathway, which is activated in HCC, is involved in invasion and metastasis through up-regulating MMP-9 in HCC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1386-6346
|
pubmed:author |
pubmed-author:BiJiongJ,
pubmed-author:CaoLiang-QiLQ,
pubmed-author:ChenJing-SongJS,
pubmed-author:ChenLian-ZhouLZ,
pubmed-author:ChenXi-LinXL,
pubmed-author:FuXin-HuiXH,
pubmed-author:HuangXiao-HuiXH,
pubmed-author:TanHao-XiangHX,
pubmed-author:WangQianQ,
pubmed-author:YdeGG,
pubmed-author:ZhangLong-JuanLJ
|
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
177-86
|
pubmed:year |
2009
|
pubmed:articleTitle |
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.
|
pubmed:affiliation |
Department of Hepatobiliary Surgery , The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
|
pubmed:publicationType |
Journal Article
|